Kapoor Shivpreet Singh 4

What Happened
Kapoor Shivpreet Singh, a director of Forte Biosciences, Inc. (FBRX), was granted 18,353 restricted stock units (RSUs) on May 29, 2026. The RSUs were awarded at $0.00 (no cash paid) and are reported as a derivative award (code A). Each RSU represents a contingent right to receive one share of common stock; the award does not immediately issue shares or represent an open‑market purchase.

Key Details

• Transaction date: 2026-05-29; Filing date (Form 4): 2026-06-02 (Accession 0002038311-26-000002).
• Award: 18,353 RSUs @ $0.00 (derivative/award).
• Vesting: 100% of the RSUs vest on the date of the first annual meeting of stockholders that occurs after May 29, 2026, conditional on continuing as a "Service Provider." (Footnotes F1 & F2)
• Shares owned after transaction: not specified in this Form 4.
• This is a compensation award (routine grant), not a market purchase or sale.

Context
RSUs are a common form of equity compensation and convert to actual shares only upon vesting; until then they are contingent and can be forfeited if service conditions aren’t met. Because this was a grant (not a purchase or sale), it’s primarily a compensation event rather than a direct signal of the insider buying or selling stock. Any issuance of shares upon vesting or subsequent sale would be reported in future filings.